» Articles » PMID: 9311921

NF-AT Activation Induced by a CAML-interacting Member of the Tumor Necrosis Factor Receptor Superfamily

Overview
Journal Science
Specialty Science
Date 1997 Oct 6
PMID 9311921
Citations 115
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of the nuclear factor of activated T cells transcription factor (NF-AT) is a key event underlying lymphocyte action. The CAML (calcium-modulator and cyclophilin ligand) protein is a coinducer of NF-AT activation when overexpressed in Jurkat T cells. A member of the tumor necrosis factor receptor superfamily was isolated by virtue of its affinity for CAML. Cross-linking of this lymphocyte-specific protein, designated TACI (transmembrane activator and CAML-interactor), on the surface of transfected Jurkat cells with TACI-specific antibodies led to activation of the transcription factors NF-AT, AP-1, and NFkappaB. TACI-induced activation of NF-AT was specifically blocked by a dominant-negative CAML mutant, thus implicating CAML as a signaling intermediate.

Citing Articles

Current status of BAFF targeting immunotherapy in B-cell neoplasm.

Tagami N, Yuda J, Goto Y Int J Clin Oncol. 2024; 29(11):1676-1683.

PMID: 39222149 PMC: 11511695. DOI: 10.1007/s10147-024-02611-2.


T cell Dissimilarities in B Cell Activating Factor-Deficient Versus B Cell Activating Factor Receptor 3-Deficient Systemic Lupus Erythematosus-Prone NZM 2328 Mice as Contributors to Their Divergent Clinical Outcomes.

Stohl W, Wu Y, Stohl M ACR Open Rheumatol. 2024; 6(11):756-768.

PMID: 39143363 PMC: 11557988. DOI: 10.1002/acr2.11712.


Novel heterozygous mutations of in EBV-associated T/NK lymphoproliferative diseases (EBV-T/NK-LPDs).

Deng X, Ge T, Shen K, Wang J, Mu W, Luo H Blood Sci. 2024; 6(1):e00180.

PMID: 38226020 PMC: 10789450. DOI: 10.1097/BS9.0000000000000180.


TNF superfamily control of tissue remodeling and fibrosis.

Steele H, Cheng J, Willicut A, Dell G, Breckenridge J, Culberson E Front Immunol. 2023; 14:1219907.

PMID: 37465675 PMC: 10351606. DOI: 10.3389/fimmu.2023.1219907.


TACI and endogenous APRIL in B cell maturation.

Garcia-Carmona Y, Fribourg M, Sowa A, Cerutti A, Cunningham-Rundles C Clin Immunol. 2023; 253:109689.

PMID: 37422057 PMC: 10528899. DOI: 10.1016/j.clim.2023.109689.